Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic significance and immune landscape of anoikis-related genes in hepatocellular carcinoma: a multi-omics analysis of subtypes and cellular communication. | Clin Exp Med | 2026 | 41543595 | PubTator, text mining | PubMed |
| Cellular basis of accelerated whole-tooth regeneration. | bioRxiv | 2026 | 41542575 | PubTator, text mining | PubMed |
| Midkine as a therapeutic node in NF1-driven neuro‑oncology: Biology, biomarkers, and translational strategies. | Biomed Pharmacother | 2026 | 41496346 | PubTator, text mining | PubMed |
| Premenopausal serum midkine levels and risk of estrogen receptor positive breast cancer: a prospective, nested case-control study. | Breast Cancer Res | 2026 | 41495788 | PubTator, text mining | PubMed |
| TDP2 drives immune evasion and metastatic progression in prostate cancer. | PLoS One | 2026 | 41481587 | PubTator, text mining | PubMed |
| Characterising interleukin-27 (IL-27) responses in human blood derived macrophage cells. | Cytokine | 2026 | 41435503 | PubTator, text mining | PubMed |
| Exploration of precise classification and therapeutic targets of breast cancer based on genes related to neuro-cancer crosstalk. | Transl Oncol | 2026 | 41406890 | PubTator, text mining | PubMed |
| The multifaceted role of midkine in gastrointestinal cancer: From biomarker to treatment. | Cancer Treat Res Commun | 2026 | 41386217 | PubTator, text mining | PubMed |
| Novel Blood-Based Biomarker Candidates in Screening for Colorectal Cancer. | Clin Colorectal Cancer | 2026 | 41290511 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals the heterogeneity and interactions among stromal and tumor cells in gastric cancer. | Transl Oncol | 2026 | 41275708 | PubTator, text mining | PubMed |
| CPE/HYOU1 axis-activated Hippo-YAP signaling pathway suppresses PANoptosis to facilitate osteosarcoma progression. | Cancer Lett | 2026 | 41213463 | PubTator, text mining | PubMed |
| Single-cell deconstruction of medulloblastoma microenvironment elucidates subtype-specific immune architectures and prognostic molecular signatures. | Cancer Lett | 2026 | 41213462 | PubTator, text mining | PubMed |
| Stress-Induced Activation of Prolactin-NR4A1-Midkine Axis Exacerbates Skin Inflammation. | Adv Sci (Weinh) | 2026 | 41194398 | PubTator, text mining | PubMed |
| Prognostic Relevance of MDK and TIMP1 with Immune Infiltration in Lung Adenocarcinoma. | Int Arch Allergy Immunol | 2026 | 40720951 | PubTator, text mining | PubMed |
| Remote neuromuscular electrical stimulation upregulates MDK to enhance macrophage efferocytosis via LRP1 in wound healing. | J Biomed Res | 2026 | 40441854 | PubTator, text mining | PubMed |
| Construction and Multi-dimensional Validation of a Lactylation-Related Signature for Glioblastoma Multiforme Prognostic and Therapeutic Purposes. | Mol Biotechnol | 2026 | 40407859 | PubTator, text mining | PubMed |
| Single-cell and machine learning integration reveals OS-driven CCND1 promotes an aggressive phenotype in papillary thyroid carcinoma. | Front Immunol | 2025 | 41646983 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptome profiling identifies the immunosuppressive spatial niche in KRAS-mutant colorectal cancer. | J Immunother Cancer | 2025 | 41475845 | PubTator, text mining | PubMed |
| SCPEP1+ basal cells are associated with the remodeling of oxidative stress signaling networks in idiopathic pulmonary fibrosis. | Front Immunol | 2025 | 41438766 | PubTator, text mining | PubMed |
| Machine learning-driven comprehensive profiling of tumor heterogeneity and sialylation in hepatocellular carcinoma. | NPJ Precis Oncol | 2025 | 41408439 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=7